• Iniciokeyboard_arrow_right
  • UC Innovationskeyboard_arrow_right
  • Technologieskeyboard_arrow_right
  • Prot IP 2.0: Innovative Penile Implant for Treating Severe Erectile Dysfunction

Prot IP 2.0: Innovative Penile Implant for Treating Severe Erectile Dysfunction

Image

Summary

Penile implants are the last line of treatment for erectile dysfunction. Since their invented 40 years ago, there have been few innovations in penile implant design and technology, which explains why they currently have significant limitations and usability problems for all users along the value chain: the patient, the patient’s partner, the urologist installing the implant, and the manufacturer.

The introduction of technological innovations through a multidisciplinary approach that improves the experience of all users, particularly the patient affected by erectile dysfunction, constitutes an opportunity for scientific and business development. 

By the year 2025, approximately 322 million men will suffer from erectile dysfunction worldwide, significantly affecting the quality of life of the patient and his partner and a common source of anxiety, depression and frustration. All patients suffering from this problem can be treated. As the world population ages, this problem will be increasingly recurrent.

The Prot IP 2.0 pre-production model is a breakthrough in the development of a pre-commercial scale penile implant that is an effective solution for treating severe erectile dysfunction, with measurable advantages from the point of view of usability, experience, implantation and manufacturing. Moreover, its safety, efficacy and resistance parameters are comparable to other implants currently available on the market. All of the above has been assessed from the perspective of patients, partners, urologists and manufacturer.

The best possible materials and manufacturing processes have been used to produce a device that meets all safety, biocompatibility, strength, functionality, high-quality and low-cost requirements.

Potential Applications

  • Treating severe erectile dysfunction
  • Better quality of life for seniors 

Development Status 

TRL 3. Proof of concept. The technology has been tested in basic laboratory assays and in human cadavers. 

Advantages

  • A more natural-feeling flaccid and erect penis
  • Activated with a single pump
  • Easier surgical implant procedure
  • Good results in terms of safety, biocompatibility, resistance and functionality
  • High-quality and low-cost device.

Intellectual Property

Preparing patent application for 2020 filing.

Opportunity

Looking for partners interested in supporting the development of a scientific-technological research project to advance laboratory testing and a pilot clinical study. 

The advantages of this technology will make it possible to open new markets and spark  demand that hasn’t been visible until now due to the proposal’s novel concept.

Research Team 

  • Marcelo Marconi, MD, Professor of Medicine 
  • Alberto González, Professor of Design
  • Ivan Caro, Professor of Design
  • Oscar Inzunza, MD, Professor of Medicine 
  • Wernher Brevis Vergara, Professor of Engineering